{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T10:58:50Z","timestamp":1740135530619,"version":"3.37.3"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T00:00:00Z","timestamp":1732233600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T00:00:00Z","timestamp":1732233600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100010425","name":"Tri-Service General Hospital","doi-asserted-by":"publisher","award":["TSGH-E-113292"],"award-info":[{"award-number":["TSGH-E-113292"]}],"id":[{"id":"10.13039\/501100010425","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Medical Affairs Bureau, Taiwan","award":["MND-MAB-C10-111038"],"award-info":[{"award-number":["MND-MAB-C10-111038"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"DOI":"10.1186\/s12888-024-06293-y","type":"journal-article","created":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T12:00:43Z","timestamp":1732276843000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Suicide-related risk among patients using branded and generic fluoxetine: a propensity score-matched, new\u2010user design in Taiwan"],"prefix":"10.1186","volume":"24","author":[{"given":"Cong-Wei","family":"Zheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Chieh","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan-Liang","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-Wen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng-Yin","family":"To","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Ting","family":"Kao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,22]]},"reference":[{"issue":"9590","key":"6293_CR1","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/S0140-6736(07)61415-9","volume":"370","author":"S Moussavi","year":"2007","unstructured":"Moussavi S, Chatterji S, Verdes E, Tandon A, Patel V, Ustun B. Depression, chronic diseases, and decrements in health: results from the World health surveys. Lancet. 2007;370(9590):851\u20138.","journal-title":"Lancet"},{"issue":"1","key":"6293_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1741-7015-9-90","volume":"9","author":"E Bromet","year":"2011","unstructured":"Bromet E, Andrade LH, Hwang I, Sampson NA, Alonso J, De Girolamo G, De Graaf R, Demyttenaere K, Hu C, Iwata N. Cross-national epidemiology of DSM-IV major depressive episode. BMC Med. 2011;9(1):1\u201316.","journal-title":"BMC Med"},{"issue":"9672","key":"6293_CR3","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1016\/S0140-6736(09)60372-X","volume":"373","author":"K Hawton","year":"2009","unstructured":"Hawton K. K van Heeringen 2009 Suicide. Lancet 373 9672 1372\u201381.","journal-title":"Lancet"},{"issue":"1","key":"6293_CR4","doi-asserted-by":"publisher","first-page":"247","DOI":"10.2147\/NDT.S2192","volume":"4","author":"M Pompili","year":"2008","unstructured":"Pompili M, Innamorati M, Raja M, Falcone I, Ducci G, Angeletti G, Lester D, Girardi P, Tatarelli R, De Pisa E. Suicide risk in depression and bipolar disorder: do impulsiveness-aggressiveness and pharmacotherapy predict suicidal intent? Neuropsychiatr Dis Treat. 2008;4(1):247\u201355.","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"9","key":"6293_CR5","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1001\/archpsyc.58.9.844","volume":"58","author":"U Osby","year":"2001","unstructured":"Osby U, Brandt L, Correia N, Ekbom A, Spar\u00e9n P. Excess mortality in bipolar and unipolar disorder in Sweden. Arch Gen Psychiatry. 2001;58(9):844\u201350.","journal-title":"Arch Gen Psychiatry"},{"issue":"4","key":"6293_CR6","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1097\/YIC.0000000000000461","volume":"38","author":"P Olgiati","year":"2023","unstructured":"Olgiati P, Fanelli G, Serretti A. Clinical correlates and prognostic implications of severe suicidal ideation in major depressive disorder. Int Clin Psychopharmacol. 2023;38(4):201\u20138.","journal-title":"Int Clin Psychopharmacol"},{"issue":"4","key":"6293_CR7","doi-asserted-by":"publisher","first-page":"e91936","DOI":"10.1371\/journal.pone.0091936","volume":"9","author":"AJ Ferrari","year":"2014","unstructured":"Ferrari AJ, Norman RE, Freedman G, Baxter AJ, Pirkis JE, Harris MG, Page A, Carnahan E, Degenhardt L, Vos T, et al. The burden attributable to mental and substance use disorders as risk factors for suicide: findings from the global burden of Disease Study 2010. PLoS ONE. 2014;9(4):e91936.","journal-title":"PLoS ONE"},{"issue":"6","key":"6293_CR8","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1056\/NEJMcp1712493","volume":"380","author":"LT Park","year":"2019","unstructured":"Park LT, Zarate CA Jr. Depression in the primary care setting. N Engl J Med. 2019;380(6):559\u201368.","journal-title":"N Engl J Med"},{"issue":"4","key":"6293_CR9","first-page":"420","volume":"16","author":"A Cipriani","year":"2018","unstructured":"Cipriani A, Furukawa TA, Salanti G, Chaimani A, Atkinson LZ, Ogawa Y, Leucht S, Ruhe HG, Turner EH, Higgins JPT, et al. Comparative efficacy and acceptability of 21 antidepressant drugs for the Acute treatment of adults with major depressive disorder: a systematic review and network Meta-analysis. Focus (Am Psychiatr Publ. 2018;16(4):420\u20139.","journal-title":"Focus (Am Psychiatr Publ"},{"issue":"9","key":"6293_CR10","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1097\/01.NAJ.0000544978.56301.f6","volume":"118","author":"D Sabella","year":"2018","unstructured":"Sabella D. Antidepressant medications. AJN Am J Nurs. 2018;118(9):52\u20139.","journal-title":"AJN Am J Nurs"},{"issue":"5","key":"6293_CR11","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1176\/ajp.122.5.509","volume":"122","author":"JJ Schildkraut","year":"1965","unstructured":"Schildkraut JJ. The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am J Psychiatry. 1965;122(5):509\u201322.","journal-title":"Am J Psychiatry"},{"issue":"12","key":"6293_CR12","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1001\/archgenpsychiatry.2010.151","volume":"67","author":"SC Marcus","year":"2010","unstructured":"Marcus SC, Olfson M. National trends in the treatment for Depression from 1998 to 2007. Arch Gen Psychiatry. 2010;67(12):1265\u201373.","journal-title":"Arch Gen Psychiatry"},{"issue":"5","key":"6293_CR13","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1517\/17460441.2014.907790","volume":"9","author":"L Perez-Caballero","year":"2014","unstructured":"Perez-Caballero L, Torres-Sanchez S, Bravo L, Mico JA, Berrocoso E. Fluoxetine: a case history of its discovery and preclinical development. Expert Opin Drug Discov. 2014;9(5):567\u201378.","journal-title":"Expert Opin Drug Discov"},{"issue":"10","key":"6293_CR14","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1016\/j.jfma.2022.02.011","volume":"121","author":"HH Wang","year":"2022","unstructured":"Wang HH, Chang CM, Chang SS, Yang AC, Liu YH, Liao SC, Wu CS. Ten-year trends in depression care in Taiwan. J Formos Med Assoc. 2022;121(10):2001\u201311.","journal-title":"J Formos Med Assoc"},{"key":"6293_CR15","unstructured":"Drugs FsOoG. Office of Generic Drugs 2023 Annual Report. In: US Food and Drug Administration. 2023."},{"issue":"1","key":"6293_CR16","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1176\/appi.ps.201100564","volume":"63","author":"TL Mark","year":"2012","unstructured":"Mark TL, Kassed C, Levit K, Vandivort-Warren R. An analysis of the slowdown in growth of spending for psychiatric drugs, 1986\u20132008. Psychiatr Serv. 2012;63(1):13\u20138.","journal-title":"Psychiatr Serv"},{"key":"6293_CR17","unstructured":"Welfare MoHa. Regulations for Registration of Medicinal products. Amended in; 2023."},{"issue":"1","key":"6293_CR18","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1080\/13696998.2021.1952795","volume":"24","author":"H Grabowski","year":"2021","unstructured":"Grabowski H, Long G, Mortimer R, Bilginsoy M. Continuing trends in U.S. brand-name and generic drug competition. J Med Econ. 2021;24(1):908\u201317.","journal-title":"J Med Econ"},{"issue":"6","key":"6293_CR19","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1016\/S0149-2918(03)80157-1","volume":"25","author":"G Borgheini","year":"2003","unstructured":"Borgheini G. The bioequivalence and therapeutic efficacy of generic versus brand-name psychoactive drugs. Clin Ther. 2003;25(6):1578\u201392.","journal-title":"Clin Ther"},{"issue":"12","key":"6293_CR20","doi-asserted-by":"publisher","first-page":"e008915","DOI":"10.1136\/bmjopen-2015-008915","volume":"5","author":"S Colgan","year":"2015","unstructured":"Colgan S, Faasse K, Martin LR, Stephens MH, Grey A, Petrie KJ. Perceptions of generic medication in the general population, doctors and pharmacists: a systematic review. BMJ Open. 2015;5(12):e008915.","journal-title":"BMJ Open"},{"issue":"2","key":"6293_CR21","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.pharep.2015.08.017","volume":"68","author":"G Cessak","year":"2016","unstructured":"Cessak G, Rokita K, D\u0105browska M, Sejbuk-Rozbicka K, Zaremba A, Mirowska-Guzel D, Ba\u0142kowiec-Iskra E. Therapeutic equivalence of antipsychotics and antidepressants - a systematic review. Pharmacol Rep. 2016;68(2):217\u201323.","journal-title":"Pharmacol Rep"},{"key":"6293_CR22","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.schres.2017.06.020","volume":"193","author":"CW Hsu","year":"2018","unstructured":"Hsu CW, Lee SY, Yang YH, Wang LJ. Comparison of the effectiveness of brand-name and generic antipsychotic drugs for treating patients with schizophrenia in Taiwan. Schizophr Res. 2018;193:107\u201313.","journal-title":"Schizophr Res"},{"issue":"10","key":"6293_CR23","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1093\/ijnp\/pyaa041","volume":"23","author":"CW Hsu","year":"2020","unstructured":"Hsu CW, Lee SY, Yang YH, Wang LJ. Brand-name antidepressants Outperform their generic counterparts in preventing hospitalization for Depression: the real-world evidence from Taiwan. Int J Neuropsychopharmacol. 2020;23(10):653\u201361.","journal-title":"Int J Neuropsychopharmacol"},{"issue":"6","key":"6293_CR24","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1001\/jama.2018.10211","volume":"320","author":"T Madsen","year":"2018","unstructured":"Madsen T, Erlangsen A, Orlovska S, Mofaddy R, Nordentoft M, Benros ME. Association between Traumatic Brain Injury and risk of suicide. JAMA. 2018;320(6):580\u20138.","journal-title":"JAMA"},{"issue":"4","key":"6293_CR25","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s40264-017-0624-0","volume":"41","author":"N Cheng","year":"2018","unstructured":"Cheng N, Rahman MM, Alatawi Y, Qian J, Peissig PL, Berg RL, Page CD, Hansen RA. Mixed Approach Retrospective analyses of suicide and suicidal ideation for brand compared with generic central nervous system drugs. Drug Saf. 2018;41(4):363\u201376.","journal-title":"Drug Saf"},{"issue":"11","key":"6293_CR26","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1001\/archpsyc.1991.01810350067011","volume":"48","author":"JJ Mann","year":"1991","unstructured":"Mann JJ, Kapur S. The emergence of suicidal ideation and behavior during antidepressant pharmacotherapy. Arch Gen Psychiatry. 1991;48(11):1027\u201333.","journal-title":"Arch Gen Psychiatry"},{"issue":"2","key":"6293_CR27","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S0165-0327(01)00377-9","volume":"68","author":"F Angst","year":"2002","unstructured":"Angst F, Stassen HH, Clayton PJ, Angst J. Mortality of patients with mood disorders: follow-up over 34\u201338 years. J Affect Disord. 2002;68(2):167\u201381.","journal-title":"J Affect Disord"},{"issue":"23","key":"6293_CR28","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1056\/NEJMp078015","volume":"356","author":"RA Friedman","year":"2007","unstructured":"Friedman RA, Leon AC. Expanding the Black Box \u2014 Depression, antidepressants, and the risk of suicide. N Engl J Med. 2007;356(23):2343\u20136.","journal-title":"N Engl J Med"},{"key":"6293_CR29","unstructured":"Organization WH. Preventing suicide: a global imperative. World Health Organization; 2014."},{"key":"6293_CR30","doi-asserted-by":"crossref","unstructured":"Hedegaard H, Curtin SC, Warner M. Suicide mortality in the United States, 1999\u20132019. NCHS Data Brief 2021(398):1\u20138.","DOI":"10.15620\/cdc:101761"},{"key":"6293_CR31","unstructured":"depression Taa. Nationwide plan of suicide prevention 2023."},{"key":"6293_CR32","doi-asserted-by":"crossref","unstructured":"Sher L, Oquendo MA. Suicide: an overview for clinicians. Med Clin 2023.","DOI":"10.1016\/j.mcna.2022.03.008"},{"issue":"9693","key":"6293_CR33","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/S0140-6736(09)60741-8","volume":"374","author":"GC Patton","year":"2009","unstructured":"Patton GC, Coffey C, Sawyer SM, Viner RM, Haller DM, Bose K, Vos T, Ferguson J, Mathers CD. Global patterns of mortality in young people: a systematic analysis of population health data. Lancet. 2009;374(9693):881\u201392.","journal-title":"Lancet"},{"key":"6293_CR34","first-page":"1","volume":"9","author":"K Piscopo","year":"2016","unstructured":"Piscopo K, Lipari RN, Cooney J, Glasheen C. Suicidal thoughts and behavior among adults: results from the 2015 National Survey on Drug Use and Health. NSDUH data Rev. 2016;9:1\u201315.","journal-title":"NSDUH data Rev"},{"issue":"13","key":"6293_CR35","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.1038\/npp.2011.163","volume":"36","author":"EL Moses-Kolko","year":"2011","unstructured":"Moses-Kolko EL, Price JC, Shah N, Berga S, Sereika SM, Fisher PM, Coleman R, Becker C, Mason NS, Loucks T. Age, sex, and reproductive hormone effects on brain serotonin-1A and serotonin-2A receptor binding in a healthy population. Neuropsychopharmacology. 2011;36(13):2729\u201340.","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"6293_CR36","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1001\/jamapsychiatry.2014.2406","volume":"72","author":"GM Sullivan","year":"2015","unstructured":"Sullivan GM, Oquendo MA, Milak M, Miller JM, Burke A, Ogden RT, Parsey RV, Mann JJ. Positron emission tomography quantification of serotonin1A receptor binding in suicide attempters with major depressive disorder. JAMA Psychiatry. 2015;72(2):169\u201378.","journal-title":"JAMA Psychiatry"},{"issue":"10","key":"6293_CR37","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.biopsych.2013.03.021","volume":"74","author":"JM Miller","year":"2013","unstructured":"Miller JM, Hesselgrave N, Ogden RT, Zanderigo F, Oquendo MA, Mann JJ, Parsey RV. Brain serotonin 1A receptor binding as a predictor of treatment outcome in major depressive disorder. Biol Psychiatry. 2013;74(10):760\u20137.","journal-title":"Biol Psychiatry"},{"issue":"3","key":"6293_CR38","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.biopsych.2005.06.037","volume":"59","author":"MA Oquendo","year":"2006","unstructured":"Oquendo MA, Russo SA, Underwood MD, Kassir SA, Ellis SP, Mann JJ, Arango V. Higher postmortem prefrontal 5-HT2A receptor binding correlates with lifetime aggression in suicide. Biol Psychiatry. 2006;59(3):235\u201343.","journal-title":"Biol Psychiatry"},{"issue":"3","key":"6293_CR39","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1017\/S0033291707001419","volume":"38","author":"A McGirr","year":"2008","unstructured":"McGirr A, Renaud J, Bureau A, Seguin M, Lesage A, Turecki G. Impulsive-aggressive behaviours and completed suicide across the life cycle: a predisposition for younger age of suicide. Psychol Med. 2008;38(3):407\u201317.","journal-title":"Psychol Med"},{"issue":"1\u20133","key":"6293_CR40","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.jad.2008.06.018","volume":"114","author":"EG Smith","year":"2009","unstructured":"Smith EG. Association between antidepressant half-life and the risk of suicidal ideation or behavior among children and adolescents: confirmatory analysis and research implications. J Affect Disord. 2009;114(1\u20133):143\u20138.","journal-title":"J Affect Disord"},{"issue":"3","key":"6293_CR41","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.seizure.2005.12.010","volume":"15","author":"P Crawford","year":"2006","unstructured":"Crawford P, Feely M, Guberman A, Kramer G. Are there potential problems with generic substitution of antiepileptic drugs? A review of issues. Seizure. 2006;15(3):165\u201376.","journal-title":"Seizure"},{"issue":"1","key":"6293_CR42","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S0163-7258(99)00048-0","volume":"85","author":"C Hiemke","year":"2000","unstructured":"Hiemke C, H\u00e4rtter S. Pharmacokinetics of selective serotonin reuptake inhibitors. Pharmacol Ther. 2000;85(1):11\u201328.","journal-title":"Pharmacol Ther"},{"issue":"S1","key":"6293_CR43","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1002\/(SICI)1520-6394(1998)8:1+<64::AID-DA10>3.0.CO;2-S","volume":"8","author":"CL DeVane","year":"1998","unstructured":"DeVane CL. Translational pharmacokinetics: current issues with newer antidepressants. Depress Anxiety. 1998;8(S1):64\u201370.","journal-title":"Depress Anxiety"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-024-06293-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12888-024-06293-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-024-06293-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T12:04:19Z","timestamp":1732277059000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/s12888-024-06293-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,22]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["6293"],"URL":"https:\/\/doi.org\/10.1186\/s12888-024-06293-y","relation":{},"ISSN":["1471-244X"],"issn-type":[{"type":"electronic","value":"1471-244X"}],"subject":[],"published":{"date-parts":[[2024,11,22]]},"assertion":[{"value":"1 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Institutional Review Board of Tri-Service General Hospital, Taiwan, approved this study (C202205001).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"No financial relationships with any organizations that could have an interest in the submitted work in the past three years. Additionally, no other relationships or activities could appear to have influenced the submitted work. Li-Ting Kao reports receiving research funding from IQVIA outside the submitted work. No other disclosures were reported.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"844"}}